Back to AVBP
WELLINGTON MANAGEMENT GROUP LLP → AVBP
WELLINGTON MANAGEMENT GROUP LLP AVBP Position History
ArriVent BioPharma, Inc. • Healthcare
Quarters held
12
Latest value
$2.4M
Q3 2026
Peak value
$2.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $472K |
| Q4 2025 | $74K |
| Q4 2025 | $1.1M |
| Q1 2026 | $553K |
| Q1 2026 | $85K |
| Q1 2026 | $1.2M |
| Q2 2026 | $1.1M |
| Q2 2026 | $153K |
| Q2 2026 | $2.2M |
| Q3 2026 | $1.4M |
| Q3 2026 | $230K |
| Q3 2026 | $2.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $2.4M | 78.7K | — | — |
| Q3 2026 | $230K | 7.6K | — | — |
| Q3 2026 | $1.4M | 47.5K | — | — |
| Q2 2026 | $2.2M | 64.4K | — | — |
| Q2 2026 | $153K | 4.4K | — | — |
| Q2 2026 | $1.1M | 32.0K | — | — |
| Q1 2026 | $1.2M | 50.6K | — | — |
| Q1 2026 | $85K | 3.7K | — | — |
| Q1 2026 | $553K | 24.0K | — | — |
| Q4 2025 | $1.1M | 55.1K | — | — |
| Q4 2025 | $74K | 3.7K | — | — |
| Q4 2025 | $472K | 23.5K | — | — |
Other funds holding AVBP
$156.9M
$149.1M
$136.5M
$119M
$105.2M
$101.5M